TDCS Stimulation After Covid-19 Infection
ConditionCOVID-19
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorIstanbul Medipol University Hospital
About this trial
In this study, the effects of bilateral stimulation of the dorsolateral prefrontal cortex (DLPFC) with active tDCS (transcranial direct stimulation/transcranial direct stimulation) on neurocognitive (memory and executive) functions in patients with Covid-19 infection and subjective cognitive complaints, as well as resting-state fMRI In the case of dfMRI, it is aimed to examine the default mode network (DMN) and parietal memory network (PMN) inter- and intra-network connectivity alterations and the hippocampal region connectivity alterations and contribute to the relevant literature.
Eligibility criteria
Qualifiers
Have received a positive value from the COVID-19 RT-PCR test in the last 60 days and turned negative
Being between the ages of 18-50
21 days have passed since the disease onset date
Disqualifiers
Having any neurological or psychiatric disease
Trial design
Treatments tested in this trial
- Transcranial Direct Stimulation
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Istanbul Medipol University Hospital
Lead sponsor
Alanya Alaaddin Keykubat University
Collaborator
Source ClinicalTrials.gov